Clinical trial
An Exploratory, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With Hepatitis B Virus(HBV)
NCT02966964 is registered in ClinicalTrials.gov with Uijeongbu St. Mary Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With Hepatitis B Virus(HBV)
- Lead sponsor
- Uijeongbu St. Mary Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 30, 2015
- Completion date
- February 28, 2019
- Enrollment
- 90 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis; virus, chronic, type b